🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI
$32.00
+8.51% 1Y
Mkt Cap$1.34B
P/E-15.70
P/B-5.61
52W High$32.97
52W Low$25.68
Book Value$-5.71
EPS (TTM)$-2.04

Company Overview

AVLN (AVLN) is a publicly traded company listed on with a market capitalization of $1.34B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 35.7%, reflecting efficient use of shareholder capital.

Growth & Price Performance

Stock Price Performance

1 Year:+8.51%
6 Months:-
3 Months:+16.66%
1 Month:+12.60%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot
52-Week Range 87% of range
$25.68 $32.97
Trend Signals
  • Price vs 50-DMAAbove
  • RSI (14)62.15 · Neutral
Price Performance
1M+12.60%
3M+16.66%
1Y+8.51%

Auto-generated from price history and fundamentals; not investment advice.

Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Strong return on equity of 35.7%.

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

Ad space

Valuation

Stock P/E
-15.70
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-5.71
Price to Book
-5.61
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-
Profit 5Y
-
Revenue (YoY)
-
Earnings (YoY)
-

Profitability & Returns

ROCE
-67.73%
ROE
35.70%
ROA
-57.23%
Profit Margin
-
Op Margin
-
Gross Margin
-
EPS (Latest Qtr)
$-0.64
EPS (TTM)
$-2.04

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
10.19
Debt
$1.67M
Total Assets
$135.66M
Current Assets
$129.99M
Working Capital
$129.47M

Ownership

Promoter Holding
0.00%
Chg in Prom Hold
-
FII / Inst Holding
61.84%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$0
EBITDA
$-91.25M
Free Cash Flow
$-81.83M
Operating Cash Flow
$-81.48M
Shares Outstanding
41.81M
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Mar 2025Mar 2026
Revenue 00
Cost of Revenue --
Gross Profit --
Operating Expenses 18.72M27.91M
Operating Income -18.72M-27.91M
EBITDA -17.49M-26.71M
Interest Expense 098.00K
Pretax Income -17.50M-26.87M
Tax Provision --
Net Income -17.50M-26.87M
Diluted EPS -0.42-0.64
R&D Expense 15.32M22.89M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2024Dec 2025
Revenue 00
Cost of Revenue --
Gross Profit --
Operating Expenses 57.12M91.29M
Operating Income -57.12M-91.29M
EBITDA -57.09M-91.25M
Interest Expense --
Pretax Income -49.74M-85.20M
Tax Provision --
Net Income -49.74M-85.20M
Diluted EPS -1.19-2.04

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2024Dec 2025
Total Assets 124.52M148.88M
Current Assets 114.39M143.56M
Cash & Equivalents 23.95M52.31M
Inventory --
Receivables 591.00K537.00K
Total Liabilities 299.04M387.54M
Current Liabilities 8.74M14.09M
Long Term Debt --
Total Debt 01.67M
Total Equity -174.52M-238.66M
Shares Outstanding 41.81M41.81M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2024Dec 2025
Operating Cash Flow -48.37M-81.48M
Investing Cash Flow -91.47M10.06M
Financing Cash Flow 89.00K99.79M
Capital Expenditure -95.00K-344.00K
Free Cash Flow -48.46M-81.83M
Net Change in Cash -139.75M28.36M

Ratios (Annual)

Figures in %.

Metric Dec 2024Dec 2025
Gross Margin % --
Operating Margin % --
Net Margin % --
ROE % 28.5%35.7%
ROCE % -49.3%-67.7%

Shareholding Pattern

Insiders
0.00%
Institutions
61.84%
Public Float
61.84%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for AVLN

Google News Sat, 25 Apr 2026

symbol__ Stock Quote Price and Forecast - CNN

<a href="https://news.google.com/rss/articles/CBMiUEFVX3lxTFB5NXJBZWs2UW9nQmlONTA3NWtQeFVXdm1VcDYyRlJSbE1BSzNYQkpfV09JRURlN1hydDJicGVQbm5lXzJoZWcycTZldTY3czlM?oc=5" target="_blank">symbol__ Stock Quote Price and Forecast</a>&nbsp;&nbsp;<fon…

Google News Mon, 01 Jun 2026

Assessing Avalyn Pharma (AVLN) Valuation As Investors React To Recent Share Price Moves - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxQaWxsMHVqaWFXVXh4QWlFeW1hNElIZXU5U1J0RElPeXVSNTdrNUtrdXRHcWZhYjBhQlIzOVdsNHdpRnJwVy1sMTRQX1ZVYlRhR3BkOWFaQjNGN1NkVEZJWmt5NHlXQ2llbXl4VEl3UDI1OVIxNkZvUy1IemlBLVdYMjE3aEM4enVvT3VKWE…

Google News Sun, 12 Apr 2026

AVLN Stock Price and Chart — NASDAQ:AVLN - TradingView

<a href="https://news.google.com/rss/articles/CBMiXEFVX3lxTE4ybkxNcVAyQmpWWkhySlFETkZMazB6enFiWm54V0VnU2YwaDhFZ2ZZMkpVNGZDTkhXcHpQbFdrS3RxLXUzZk11T3U2clZUdWpXclBucXRmTVh5ME9N?oc=5" target="_blank">AVLN Stock Price and Chart — NASDAQ:AVLN</a…

Google News Mon, 27 Jul 2026

Avalyn Pharma (NASDAQ:AVLN) Shares Gap Down - Time to Sell? - MarketBeat

<a href="https://news.google.com/rss/articles/CBMiqwFBVV95cUxPRHd4OWJiRW4xRkllQmwtWl94UW5vVkUwLTFMR210QkFIUHdsVFdkMmhtek5NNmR3b1p6ODMwaUREWkpOQVg1Y0syN2hncUxMRnNjOWxyZVVuT2tKXzJYeDh5c21MSU5HRmgzelVqMXFUUjRtMmljUjJwXzc3YW43cldDcnlMalpBd1I3dD…

Google News ue, 28 Jul 2026

Avalyn Pharma Inc. - common stock (AVLN) Stock Price, News, Quote & History - financialcontent.com

<a href="https://news.google.com/rss/articles/CBMiWkFVX3lxTE1ZeXFzUUJITDFnMk1rSVRjT2VpS2JsUVVDLV9oMy1xdXVLNmV4UnAtd0RwdUMwYUFvUXhmN1NvVVBTSkRZR1JsVXNNQkJCSkozMmFLZXNFMUY3dw?oc=5" target="_blank">Avalyn Pharma Inc. - common stock (AVLN) Stoc…

Google News Fri, 01 May 2026

Avalyn Pharma Inc. (AVLN) Stock Price Today: $28.58 - Gotrade

<a href="https://news.google.com/rss/articles/CBMiV0FVX3lxTFB3M1FoQkU4c0U3SFhVY2oyZ3RDQmVIOVFUN1lTMVRTZGw3eUdveExfVm1SY3kyTjJDVWpSSHBpMXh4RXYtTml4am43VjhqZFY1YjF0TWJhRQ?oc=5" target="_blank">Avalyn Pharma Inc. (AVLN) Stock Price Today: $28.…

AVLN — Frequently Asked Questions

What is the current share price of AVLN?

As of 2026-08-05 17:25 PDT, AVLN trades at $32.00 on NASDAQ/NYSE. Its 52-week range is $25.68 to $32.97.

What is the market capitalisation of AVLN?

AVLN has a market capitalisation of $1.34B on NASDAQ/NYSE.

What is the P/E ratio of AVLN?

AVLN trades at a trailing price-to-earnings (P/E) ratio of -15.70. Its price-to-book (P/B) ratio is -5.61.

What is the return on equity (ROE) of AVLN?

AVLN has a return on equity (ROE) of 35.70%. Its return on capital employed (ROCE) is -67.73%.

Is AVLN a good stock to buy?

This page provides a data-driven analysis of AVLN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks